Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone

Journal of Psychiatric Research

Volumn 37, Issue 6, 2003, Pages 463-470

  Schuld, Andreas ^a   Schmid, Dagmar A ^a   Haack, Monika ^a   Holsboer, Florian ^a   Friess, Elisabeth ^a   Pollmächer, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Cortisol; Interleukins; Stress; Tumor necrosis factor

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN RELEASE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL;

EID: 0141957380     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(03)00054-2     Document Type: Article

References (22)

1. Diagnostic and statistical manual of mental disorders. IVth ed:1994;American Psychiatric Press, Washington DC.
2. Baram T.Z., Mitchell W.G., Halden E. Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans. Molecular Psychiatry. 1:1996;320-324.
3. Barber A.E., Coyle S.M., Marano M.A., Fischer E., Calvano S.E., Fong Y., Moldawer L.L., Lowry S.F. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. Journal of Immunology. 150:1993;1999-2006.
4. Bornstein S.R., Chrousos G.P. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex. neural and immune inputs Journal of Clinical Endocrinology and Metabolism. 84:1999;1729-1736.
5. Bratts R., Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Alimentation, Pharmacology and Therapeutics. 10(Suppl 2):1996;81-90.
6. Gold P.W., Chrousos G.P. The endocrinology of melancholic and atypical depression. relation to neurocircuitry and somatic consequences Proceedings of the Association of American Physicians. 111:1999;22-34.
7. Haack M., Hinze-Selch D., Fenzel T., Kraus T., Kühn M., Schuld A., Pollmächer T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission. effects of confounding factors and diagnosis Journal of Psychiatric Research. 33:1999;407-418.
8. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery Psychiatry. 23:1960;56-62.
9. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test. a refined laboratory test for psychiatric disorders Journal of Psychiatric Research. 28:1994;341-356.
10. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
11. Keck M.E., Welt T., Wigger A., Renner U., Engelmann M., Holsboer F., Landgraf R. The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats. European Journal of Neuroscience. 13:2001;373-380.
12. Leonard B. Stress, depression and the activation of the immune system. World Journal of Biological Psychiatry. 1:2000;17-25.
13. Maes M. Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology. 461:1999;25-46.
14. Maes M., Bosmans E., Meltzer H.Y. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. European Archives of Psychiatry and Clinical Neuroscience. 245:1995;172-178.
15. Maes M., Scharpe S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., Cosyns P. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Research. 49:1993;11-27.
16. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
17. Rubinow D.R., Post R.M., Savard R., Gold P.W. Cortisol hypersecretion and cognitive impairment in depression. Archives of General Psychiatry. 41:1984;279-283.
18. Schuld A., Kraus T., Haack M., Hinze-Selch D., Zobel A.W., Holsboer F., Pollmächer T. Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients. Psychoneuroendocrinology. 26:2001;65-76.
19. Schuld A., Mullington J., Friess E., Hermann D.M., Galanos C., Holsboer F., Pollmächer T. Changes in dehydroepiandrosterone (DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. Journal of Clinical Endocrinology and Metabolism. 85:2000;4624-4629.
20. Späth-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier H., Marshall L., Burger K., Fehm H.L., Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. Journal of Clinical Endocrinology and Metabolism. 83:1998;1573-1579.
21. Tilders F.J., DeRijk R.H., Van Dam A.M., Vincent V.A., Schotanus K., Persoons J.H. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins. routes and intermediate signals Psychoneuroendocrinology. 19:1994;209-232.
22. Zobel A.W., Nickel T., Künzel H.E., Ackl N., Sonntag A., Ising M., Holsboer F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression. the first 20 patients treated Journal of Psychiatric Research. 34:2000;171-181.